EGFR and early-onset autosomal dominant Alzheimer disease: Other UK Biobank affiliated researchers utilized scRNA-seq to support the role of EGFR in Alzheimer’s disease pathology and characterize the context of EGFR signaling that could be utilized for developing future targeted therapeutics for Alzheimer’s disease (He et al., 2021).